$873.18
Value $259B
GS and HIPO stock compared: price, dividend, valuation and results, from SEC filings.
$873.18
Value $259B
$36.83
Value $957M
Goldman Sachs (GS) has a market value of $259B and Hippo (HIPO) $957M. Over the last year, with dividends, GS moved +14.8% and HIPO +16.8%. The P/E is 12.2 for GS and 29.9 for HIPO. Dividend yield: GS 2.06%, HIPO none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
GS$259B
HIPO$957M
GS is 271 times HIPO
Revenue, 12 months
GS$69.7B
HIPO$543M
GS is 128 times HIPO
Net income, 12 months
GS$22.2B
HIPO$32M
GS is 693 times HIPO
Operating margin
GS–
HIPO–
ROIC
GS11.3%
HIPO7.1%
4.2 points apart
P/E
GS12.2
HIPO29.9
HIPO is 2.5 times GS
Dividend yield
GS2.1%
HIPO0.0%
2.1 points apart
5-year return
GS+151.7%
HIPO-61.5%
213.2 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
GS+151.7%
HIPO-61.5%
| Period | GSWith dividends | HIPOWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +14.8%Price +12.6% | +16.8%Price +16.8% |
| 3 years since November 17, 2023 | +175.1%+40.1% a yearPrice +157.4% | +356.4%+65.9% a yearPrice +356.4% |
| 5 years since November 17, 2021 | +151.7%+20.3% a yearPrice +123.0% | -61.5%-17.4% a yearPrice -61.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
GSGoldman SachsHIPOHippo
| Price | $873.18 | $36.83 |
|---|---|---|
| Market value | $259B | $957M |
| Enterprise value (EV) | – | $582M |
| P/E | 12.2 | 29.9 |
| P/E, 5-year median | 14.1 | – |
| P/B | 2.4 | 2.0 |
| EV/EBIT | – | 17.2 |
| Free cash flow yield | – | 13.3% |
| Revenue, 12 months | $69.7B | $543M |
|---|---|---|
| Net income, 12 months | $22.2B | $32M |
| Free cash flow, 12 months | – | $127M |
| Earnings per share, 12 months | $69.53 | $1.23 |
| Revenue growth, year on year | 8.9% | 25.9% |
| Revenue growth a year, past | +5.5%over 5 years | +55.5%over 5 years |
| EPS growth a year, past | +15.7%over 5 years | – |
| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 31.8% | 5.9% |
| ROIC | 11.3% | 7.1% |
| ROE | 17.9% | 7.1% |
| Cash | $455B | $375M |
|---|---|---|
| Total debt | $389B | $3.2M |
| Net debt / EBITDA | – | -6.9 |
| Interest cover | – | – |
| Dividend yield | 2.1% | – |
|---|---|---|
| Dividend per share, 12 months | $18.00 | – |
| Dividend growth a year, past | +22.9%over 5 years | – |
| Buyback yield | 4.8% | 1.5% |
| Shareholder yield | 6.8% | 1.5% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Goldman Sachs ($259B) is about 270.9 times Hippo ($957M), at today's prices.
Since November 17, 2021, GS's price moved +123.0% and HIPO's -61.5%. With dividends: GS +151.7% (+20.3% a year), HIPO -61.5% (-17.4% a year). Past returns do not predict future ones.
The dividend yield at today's price is 2.06% for Goldman Sachs and none for Hippo. Over the last twelve months they paid $18.00 and – per share.
At today's price, the P/E is 12.2 for GS and 29.9 for HIPO. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 31.8% for Goldman Sachs and 5.9% for Hippo, and the operating margin – and –. Revenue was $69.7B and $543M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.